Drug Type Small molecule drug |
Synonyms Apramycin (USAN/INN), Nebramycin II, EL-857 + [2] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H41N5O11 |
InChIKeyXZNUGFQTQHRASN-XQENGBIVSA-N |
CAS Registry37321-09-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Phase 1 | Germany | 02 Sep 2019 | |
Neoplasms | Preclinical | France | - |
Phase 1 | 16 | ofxaxurwrl = sfbznhcntn oxjhsyfkal (mybgtieolm, iplmwrhstw - noopacauoi) View more | - | 10 Dec 2024 |